Franklin Resources
XERS icon

Franklin Resources’s Xeris Biopharma Holdings XERS Stock Holding History

Franklin Resources’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$465K Sell
80,217
-41,211
-34% -$273K ﹤0.01% 2492
2025
Q4 		$953K Buy
121,428
+12,286
+11% +$96.7K ﹤0.01% 2108
2025
Q3 		$888K Buy
109,142
+5,864
+6% +$39K ﹤0.01% 2165
2025
Q2 		$482K Sell
103,278
-4,658
-4% -$21.3K ﹤0.01% 2333
2025
Q1 		$593K Buy
107,936
+88,375
+452% +$357K ﹤0.01% 2195
2024
Q4 		$66.3K Hold
19,561
– – ﹤0.01% 2784
2024
Q3 		$58.1K Buy
19,561
+73
+0.4% +$187 ﹤0.01% 2789
2024
Q2 		$43.8K Buy
+19,488
New +$39.3K ﹤0.01% 2741
2023
Q3 		– Sell
-63,703
Closed -$167K – 2797
2023
Q2 		$167K Buy
+63,703
New +$162K ﹤0.01% 2430

Other funds holding XERS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return